W N Burnette
Overview
Explore the profile of W N Burnette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
2757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Burnette W, Arciniega J, Mar V, Burns D
Infect Immun
. 1992 Jun;
60(6):2252-6.
PMID: 1587592
The subunits that make up the pentameric B oligomer of pertussis toxin (S2, S3, S4, and S5) were individually synthesized as recombinant polypeptides in Escherichia coli, isolated as insoluble inclusion...
12.
Burnette W, Mar V, Whiteley D, BARTLEY T
J R Soc Med
. 1992 May;
85(5):285-7.
PMID: 1433093
No abstract available.
13.
14.
Saukkonen K, Burnette W, Mar V, Masure H, Tuomanen E
Proc Natl Acad Sci U S A
. 1992 Jan;
89(1):118-22.
PMID: 1729677
Bordetella pertussis is bound to glycoconjugates on human cilia and macrophages by multiple adhesins, including pertussis toxin. The cellular recognition properties of the B oligomer of pertussis toxin were characterized...
15.
Burnette W
Curr Opin Biotechnol
. 1991 Dec;
2(6):882-92.
PMID: 1367964
Research that may lead to the development of recombinant DNA-based vaccines has been conducted on a broad front. This has resulted in an increased understanding of immunological responsiveness to vaccines,...
16.
Burnette W, Mar V, Platler B, Schlotterbeck J, McGinley M, Stoney K, et al.
Infect Immun
. 1991 Nov;
59(11):4266-70.
PMID: 1937784
Cholera and pertussis toxins each contain a subunit with ADP-ribosyltransferase activity, sharing a region of nearly identical amino acid sequence near the NH2 terminus. Previous investigations have shown that substitution...
17.
Arciniega J, Shahin R, Burnette W, BARTLEY T, Whiteley D, Mar V, et al.
Infect Immun
. 1991 Oct;
59(10):3407-10.
PMID: 1894354
An enzymatically deficient recombinant S1 subunit, in which Arg-9 was replaced by Lys, was combined with native B oligomer to form a mutant holotoxin molecule. This molecule exhibited decreased leukocytosis-promoting...
18.
Burnette W, Mar V, BARTLEY T, Kaslow H, Cieplak Jr W, Keith J, et al.
Dev Biol Stand
. 1991 Jan;
73:75-8.
PMID: 1778336
The demand for a safer pertussis vaccine has led to the development of acellular vaccine products. We have sought to manufacture a component vaccine based upon the genetic inactivation of...
19.
20.
Cieplak Jr W, Locht C, Mar V, Burnette W, Keith J
Biochem J
. 1990 Jun;
268(3):547-51.
PMID: 2363691
The S1 subunit of pertussis toxin catalyses the hydrolysis of NAD+ (NAD+ glycohydrolysis) and the NAD(+)-dependent ADP-ribosylation of guanine-nucleotide-binding proteins. Recently, the S1 subunit of pertussis toxin was shown to...